Loading chat...
NJ A3030
Bill
Status
1/9/2024
Primary Sponsor
Clinton Calabrese
Click for details
AI Summary
-
Requires the Division of Consumer Affairs to establish a process allowing patients to voluntarily add an indication to their prescription monitoring information that they should not be prescribed opioid drugs or other controlled substances with significant abuse or addiction potential
-
Creates a patient-initiated process to remove the "do not prescribe" indication from their prescription monitoring profile at any time
-
Mandates the division establish a method for patients with this preference to communicate it even when incapacitated or unable to communicate during healthcare services
-
Requires the Division of Consumer Affairs to develop an education and outreach program for healthcare providers about this new patient preference system
-
Aims to support recovery efforts, help patients maintain sobriety, and assist practitioners in identifying patients at risk of abusing or diverting prescription medications
Legislative Description
Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.
Health
Last Action
Introduced, Referred to Assembly Health Committee
1/9/2024